Penserra Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,863
| Closed | -$2.54M | – | 1255 |
|
|
2024
Q2 | $2.54M | Buy |
23,863
+3,839
| +19% | +$409K | 0.03% | 327 |
|
|
2024
Q1 | $1.94M | Buy |
20,024
+4,088
| +26% | +$395K | 0.02% | 357 |
|
|
2023
Q4 | $1.61M | Buy |
15,936
+5,142
| +48% | +$519K | 0.03% | 312 |
|
|
2023
Q3 | $1.1M | Buy |
10,794
+5,301
| +97% | +$540K | 0.02% | 340 |
|
|
2023
Q2 | $554K | Buy |
5,493
+1,896
| +53% | +$191K | 0.01% | 491 |
|
|
2023
Q1 | $330K | Buy |
3,597
+2,616
| +267% | +$240K | 0.01% | 594 |
|
|
2022
Q4 | $88K | Buy |
981
+504
| +106% | +$45.2K | ﹤0.01% | 822 |
|
|
2022
Q3 | $36K | Buy |
+477
| New | +$36K | ﹤0.01% | 842 |
|